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ABSTRACT 
Poly(ethylene glycol)-coated Au nanocages have been evaluated as a potential near-infrared (NIR) contrast agent for 
photoacoustic tomography (PAT).  Previously, Au nanoshells were found to be an effective NIR contrast agent for 
PAT; however, Au nanocages, with their more compact sizes (<50 nm compared to >100 nm for Au nanoshells) and 
larger optical absorption cross-sections, should be better suited for in vivo applications.  In this study, we tested Au 
nanocages as a contrast agent for PAT.  The result suggests that Au nanocages are promising contrast agents for our 
applications.  We also present PAT results when novel, dye-containing nanoparticles are used as contrast agents. 
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1. INTRODUCTION 
Photoacoustic tomography (PAT) is a novel, hybrid, and non-ionizing imaging modality that combines the merits of 
both purely optical imaging and ultrasonic imaging methods.  It is also highly sensitive to the optical absorption of 
biological tissue.  PAT provides greater spatial resolution than purely optical imaging in deep regions while 
simultaneously overcoming the disadvantages of ultrasonic imaging regarding both biochemical contrast and speckle 
artifact; it can provide high spatial resolution images with optical contrast in a region up to 5.2 cm deep.1 
 
PAT has been successfully applied to the visualization of different structures in biological tissues and has been 
especially useful in imaging the cerebral cortex of small animals. 2-6  PAT is also suitable for monitoring the circulation 
of exogeneous optical contrast agents.7,8  Such contrast agents have been shown to improve the sensitivity and 
specificity of optical imaging techniques such as optical coherent tomography (OCT), fluorescence imaging, and other 
microscopies.9  Still, purely optical imaging techniques cannot provide high spatial resolution in regions beyond 1 mm 
deep because of the strong scattering from biological tissues. 
 
Long-circulating, optically tunable nanoparticles have recently been applied to PAT for use as contrast agents, allowing 
for their uptake, delivery, and excretion from a body to be monitored.  The results from such monitoring could aid in the 
diagnosis of cancer.  For example, these small (typically 60 to 400 nm diameter) particles tend to extravate and 
accumulate in tumor regions via a passive mechanism referred to as the “enhanced permeability and retention effect,” 
which has been attributed to dysfunctional anatomical conditions such as localized leaky circulatory and lymphatic 
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systems.  This feature is especially helpful in brain tumor detection since healthy vessels in the brain dissuade the 
extravasation of such particles because of the blood-brain barrier. As a result, nanoparticles can accumulate in the 
vicinity of tumor vasculature and greatly enhance NIR optical contrast.  In a previous study, Au nanoshells were tested 
as a NIR optical contrast agent in PAT.  In this study, we have sought to evaluate a new class of optically tunable 
nanoparticles, Au nanocages, as a potential NIR contrast agent for PAT. 
 
This work aims to tailor the optical properties of the Au nanocages for use with PAT.  To this end, we have prepared Au 
nanocages with an average edge length of ~50 nm.  Discrete dipole approximation (DDA) calculations indicate that 
these small, hollow Au nanostructures have a particularly large absorption cross-section, nearly 5 orders of magnitude 
greater than that of conventional organic dyes.10  This feature is attractive to absorption-based imaging techniques such 
as PAT.  Specifically, we show the feasibility of Au nanocages as an intravascular contrast agent for PAT of small 
animals in vivo.  The vasculature of a rat’s cerebral cortex was imaged, with enhanced optical contrast being observed 
with the use of Au nanocages. 
 
We also tested NIR dyes-containing nanoparticles as PAT contrast agents.  Cabocyanine dyes are the most widely used 
NIR optical probes for imaging tumors in small animals and humans.  They have exceptionally high molar absorptivity 
(typically 105 M-1cm-1).  Among cabocyanine dyes, indocyanine green (ICG) is particularly useful because it has been 
proved by the U.S. Food and Drug Administration for clinic applications.  It has been used in various imaging 
applications such as cardiac output monitoring, hepatic function study, peripheral circulation assessment and tumor 
detection. However, ICG has several disadvantages.  First, when administered intravenously, ICG has a plasmatic half-
life of 2-4 minutes and shows extensive protein binding.  The short circulation time and protein binding prevent it from 
effective use as a fluorescent probe for optical imaging.  Second, ICG is degraded in aqueous solution and the 
degradation is accelerated by light and heat.  The degradation makes it impossible to prepare a stable ICG bio-conjugate 
in the aqueous media.  Consequently, several ICG derivatives have been developed.  These derivatives are reactive and 
are more stable in aqueous media.  However, the toxicity and biocompatibility of these ICG derivatives have not been 
fully investigated.   
 
Phosphorex, Inc. has long been developing and commercializing near-IR nanoparticles.  The nanoparticles Phosphorex 
developed have sizes ranging from 50 nm to 500 nm.  At Phosphorex, ICG and other near-IR dyes have been 
encapsulated in various polymer matrixes to form nano-sized particles or spheres.  Here we present the PAT results 
using these nanopaticles as contrast agents. 
2. METHODS AND MATERIALS 
Au nanocages with an edge length of ~50 nm were prepared in a two-step process.  First, Ag nanocubes were prepared 
by a modified polyol process.11  6.0 mL of ethylene glycol (EG, J.T. Baker 9300-01 Lot C42B27) was added to a glass 
vial and heated at 152 °C for 1 hour while being stirred with a Teflon-coated magnetic stir bar at 260 rpm’s.  90 µL of a 
3 mM sodium sulfide (J. T. Baker 3910)-EG solution was then injected into the vial.  After 8.5 minutes, 1.5 mL of a 
PVP (20 mg/mL, J. T. Baker, cat. no. 3910, MW = 29,000)-EG solution was injected into the vial.  Immediately 
thereafter, 0.50 mL of a AgNO3 (48 mg/mL, Sigma-Aldrich 209139)-EG solution was injected into the vial.  A series of 
color changes were observed over the next 12 minutes, with the reaction being stopped by cooling the vial to room 
temperature after the reaction media appeared opaque, green-ochre when viewed head-on and ruddy-red when viewed 
from the top.  Plating was observed on the vial walls.  The quenched reaction media was then diluted twice its volume 
with acetone and the Ag nanocubes were collected by centrifugation.  The Ag nanocubes were resuspended in water and 
washed an additional 3 times then stored in 4 mL of deionized water for future use.   
 
The Ag nanocubes were converted into Au nanocages via the galvanic replacement reaction.  400 µL of the Ag 
nanocubes were dispersed in 10 mL water containing 1 mg/mL PVP in a 50 mL flask under magnetic stirring.  The 
suspension was heated to a gentle reflux (~10 minutes).  Then 5.4 mL of a 0.5 mM HAuCl4 aqueous solution was added 
to the flask via syringe pump at a rate of 0.75 mL/min.  Upon completion of HAuCl4 solution addition, the suspension 
appeared dark blue.  The suspension remained heated for an additional 10 minutes.  Once cooled to room temperature, 
the sample was saturated with NaCl (to remove AgCl) then spun down.  The supernatant was discarded and the sample 
resuspended in water.  The sample was washed 6 additional times to remove PVP and NaCl.  The Au nanocage optical 
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properties were assessed using a UV-visible spectrophotometer.  The resulting Au nanocages had a peak optical 
extinction (absorption and scattering) at ~820 nm (Figure 1), a wavelength that overlaps with the optically transparent 
window of biological tissues and the laser employed in the PAT experiments. 
 
The concentration of Ag nanocubes was determined by correlating atomic emission spectroscopy with SEM, with ~10 
% of the anticipated Au nanocages being lost during washing. The Au nanocages were then  functionalized with 
poly(ethylene glycol) (PEG), which has been shown to suppress immunogenic responses and thus improve blood 
circulation times.12,13   Au nanocage surfaces were functionalized with PEG by adding 1 mL of a 1mM mPEG-SH (5000 
MW PEG-SH, Nektar)-water solution to a 2 nM cage suspension.  The suspension was gently agitated then allowed to 
sit undisturbed overnight.  Residual mPEG-SH was removed by centrifugation.  
 
Dye-containing nanoparticles were obtained from Phosphorex, Inc.  At Phosphorex, ICG has been encapsulated in 
various polymer matrixes to form ICG nanoparticles.  These nanoparticles are received from Phosphorex, Inc. and 
tested in our PAT imaging system.  The properties of these nanoparticles are listed in the above table (Table 1). 
 
 
Figure 1. Absorption spectra of Ag nanocubes and Au nanocages.  
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The setup for noninvasive photoacoustic tomography of rat brains is shown in Figure 2.  A Q-switched Nd:YAG laser 
(LS-2137/2, LOTISTII)-pumped tunable Ti:sapphire laser (LT-2211A, LOTIS TII) was employed to provide laser 
pulses with a FWHM < 15 ns, a pulse repetition rate of 10 Hz, and a wavelength of 804 nm.  The incident energy 
density of the laser beam was controlled to be less than 10 mJ/cm2 on the surface of the rat head, which is well below 
the ANSI limit (32 mJ/cm2 at 804 nm).  An unfocused ultrasonic transducer (V310, Panametrics) with a central 
frequency of 10 MHz and a -6dB bandwidth of about 70% was used to detect the ultrasound signals.  The rat was fixed 
with a homemade mount so that its head protruded into the water tank through a hole in the tank’s bottom, with a piece 
of polyethylene film sealing the gap between the water and the rat’s head.  Ultrasonic coupling gel was applied on the 
surface of the rat head.  The photoacoustic signals detected by the ultrasonic transducer were received by an amplifier 
and then sent to an oscilloscope.  A computer collected the digitized signals to reconstruct the distribution of optical 
Sample ID Effective Dye Conc. 
(mg/ml) 
Recommended 
Injection Volume 
(ml/100g) 
NIRexTM-4002 300 0.25 
NIRexTM-4004 125 0.6 
Table 1 Phosphorex Dye-Containing Nanoparticles  
Figure 2  Experimental setup 
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absorption in the imaging plane through a modified backprojection algorithm.14   
 
Sprague Dawley rats (100-150 g, Harlan Sprague Dawley, Inc., Indianapolis, Indiana) were employed for the imaging 
experiments. Before imaging, the hair on each rat’s head was removed with hair removal lotion. A dose of 85 mg/kg 
Ketamine plus 15 mg/kg Xylasine was administered intramuscularly to anesthetize the rats.  The subsequent anesthesia 
was achieved by the inhalation of a mixture of O2 and isoflourane. The heart rate and blood oxygenation (SpO2) level 
were monitored by a pulse oximeter. The heart rate of the animals was ~300 bpm and the SpO2 level was >98% during 
the data acquisition.  
 
The nanocages were injected into the circulatory system of the rats through the tail veins or saphenous veins.  Three 
successive injections of nanocages were administrated, each with a dose of ~0.8 ×  109 nanocages/g body weight.  PAT 
scanning started immediately following each administration.  After three administrations, PAT scanning was 
continuously performed for up to 6 hours.  After data acquisition, the rat was sacrificed with an injection of 
concentrated pentobarbital.  Open skull surgery was performed to photograph the cerebral cortex.  With another animal, 
a single injection with a dose of ~0.8 X 109 nanocages/g body weight was also performed, and PAT scanning 
immediately followed the injection and continued for about 3 hours.  For dye-containing nanoparticles, only one 
injection was used for all test. 
3. RESULTS 
Figure 3 Non-invasive PAT imaging of a rat's cerebral cortex (A) before the injection of 
nanocages; (B) about 2 hours after the final injection of nanocages, which is the peak 
enhancement point. (D) An open-skull photograph of the rat's cerebral cortex.  Three successive 
injections were administrated in these results. 
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3.1 Results for Au Nanocacges 
PAT images of the cerebral cortex of a rat of the three successive injections are presented in Figures 3A and 3B with the 
same color bars.  Figure 3A shows the cerebral cortex imaging before the injection of nanocages while Figure 3B is 
after the injection of nanocages.  Compared to Figure 3A in which only intrinsic optical contrast provides the image, 
Figure 3B, acquired after the administration of Au nanocages, shows the brain vasculature with much greater clarity.  
With Au nanocages, the optical absorption of the blood was increased and the contrast between the vessels and the 
background brain tissues was enhanced.  All the PAT images of the rat brain match well with the open-skull anatomical 
photograph shown in Figure 3C.  
 
The absorption spectrum of the nanocages mixed with rat blood was also measured ex vivo by detecting photoacoustic 
signals.  First, nanocages were mixed with rat blood at a ratio equivalent to ~0.8 ×  109 nanocages/g body weight, and 
injected into a small Tygon tube (0.94 mm OD, 51 mm ID).  The tube was then illuminated by the laser while the 
generated photoacoustic signals were detected with a ultrasonic transducer.  The laser wavelength was tuned from 764 
nm to 824 nm, and the photoacoustic signals were collected.  As a reference, the absorption spectrum for pure rat blood 
was also measured.  This result is shown in Figure 4A.  Figure 4A shows that with blood only, the amplitudes of 
measured photoacoustic signals are considerably lower.  After adding the Au nanocages into the blood, the amplitudes 
increase by 85-106% over this wavelength range.  The increases in optical absorption in vivo were also calculated for all 
PAT images.  Figure 4B shows the enhancement result for a single injection.  In Figure 4B, the enhancements have a 
peak value of 35 %, which occurs about 2 hours after the injection.   
 
 
Figure  4  A) Ex vivo measurements of optical absorption spectral of rat blood with and without Au 
nanocages.  B) The integrated absorption calculated from the experimental images for the single-
injection experiment. The presented values are normalized by the integrated absorption of the 
image obtained before the injection.  The error bars are the standard errors for each integration 
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To further compare Au nanoshells and Au nanocages, we simulated the extinction spectra for both nanoparticles in 
water using the DDA approach.  The parameters used in the simulation were nm125D nm,145D inout ==  with a shell 
thickness of 10 nm for the Au nanoshells and nm42edgeInner  nm,50edgeOuter == with a wall thickness of 4 nm for 
the Au nanocages.  These dimensions are similar to those materials used in the previous7 and current work.  The DDA 
results are shown in Figure 5.  Overall, Au nanoshells have a much greater extinction value than Au nanocages; 
however, the extinction of Au nanoshells is dominated by scattering.  In contrast, the extinction spectrum of the Au 
nanocages is dominated by absorbance.  As a result, at 800 nm, Au nanocages have greater absorbance than Au 
nanoshells (0.036 vs. 0.027 µm2).  Since PAT is an absorption-based technique, the greater absorption of the Au 
nanocages makes them more suitable than Au nanoshells for use as a contrast agent, as demonstrated in this study  
Another feature showed by this result is that Au nanocages have much narrower absorbance peak than Au nanoshells, 
and therefore more sensitive to laser wavelength. 
 
3.2 Results for dye-containing Nanoparticles 
The results for NIRexTM-4002 are shown in Figure 6.  Two PAT images of the cerebral cortex of a rat are presented in 
Figures 6A and 6B.  Figure 6A shows the cerebral cortex imaging before the injection of nanoparticles while Figure 6B 
is the image after the injection of nanoparticles.  Compared with Figure 6A in which only intrinsic optical contrast 
Figure 5 Extinction spectra calculated using Mie theory and the discrete dipole approximation (DDA) 
method for (A) a Au nanoshell composed of a SiO2 core (diameter = 125 nm) and 10-nm thick Au shell 
and (B) a Au nanocage with an edge length of 50 nm and wall thickness of 4 nm, respectively.  Both 
were simulated to be in a water environment. 
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provides the image, Figure 6B, acquired after the administration of Au nanocages, shows the brain vasculature with 
greater clarity.  With nanoparticles, the optical absorption of the blood was increased and the contrast between the 
vessels and the background brain tissues was enhanced.  A differential image is shown in Figure 6C and was obtained 
by subtracting the amplitude of the pre-injection image (Figure 6A) from that of the post-injection image (Figure 6B).  
This image displays the distribution of differential optical absorption in the rat brain as induced by the exogenous 
contrast agent.  The increases in optical absorption after nanopariticle injection were calculated.  The signals were 
integrated over each image and then normalized to the signal integration of the reference image.  The result is shown in 
Figure 6C.  The enhancement reaches about 50% after injection, and maintained for over 3 hour.  The experiment was 
terminated because the unstable condition of the animal.  Testing results for NIRexTM-4004 is shown in Figure 7.  These 
results are similar to that in Figure 6, but only the enhancement reaches about 25% after injection, and reduced after that 
due to the clearance of nanopaticles from blood. 
 
 
 
 
 
 
Figure 6 Sample NIRexTM-4002 was injected.  Non-invasive PAT imaging of a 
rat's cerebral cortex (A) before the injection of nanoparticles; (B) about 2 hours 
after the final injection of nanoparticles, which is the peak enhancement point. (C) 
A pixel-wise differential image (image B – image A) (D) The integrated 
absorption calculated from the experimental images. 
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4. SUMMARY 
We have shown that Au nanocages and NIR dye-containing nanoparticles can be used in photoacoustic imaging to 
enhance the contrast between the blood vessels and the surrounding tissues.  The enhanced contrast could allow more 
detailed vascular structures to be imaged at greater depths.  Our results demonstrate that these nanoparticles are suitable 
contrast agents for imaging techniques based on optical absorption and in particular PAT.  We envision that 
photoacoustic-based imaging using bioconjugated nanoparticles to target cancer cells could provide a new tool for 
tumor detection.  
 
Figure 7 Sample NIRexTM-4004 was injected.  Non-invasive PAT imaging of a 
rat's cerebral cortex (A) before the injection of nanoparticles; (B) about 2 hours 
after the final injection of nanoparticles, which is the peak enhancement point. 
(C) A pixel-wise differential image (image B – image A) (D) The integrated 
absorption calculated from the experimental images.  
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